Medicare Drug Negotiations Target Ozempic and I...

By Rene Pretorius

January 17, 2025

Medicare drug negotiations represent a significant ongoing effort to lower prescription medication costs under the Inflation Reduction Act. The late...
Pharmaceutical Data Collaboration Between Canada’s Drug Agency and CIHI
Promising Results for Imlunestrant in Advanced ER+ HER2- Breast Cancer
CMS Price Negotiations: Bridging the Gap in US Drug Pricing
Access to Anti-Obesity Medication for Medicare and Medicaid
Zepbound Outperforms Wegovy in Weight Loss Trial
Canada’s Drug Agency Launches Consultation on New Methods Guide for Hea...
Sanofi’s 340B Rebate Model: A Joint Effort to Reform Drug Pricing Pract...
Lawsuits Challenge 340B Drug Pricing Program: Eli Lilly and J&J vs. HRSA
Enhancing Rare Disease Decision-Making Through Integrated Data Linkage in Canada
AI-Ready Dataset Revolutionizes Type 2 Diabetes Research
Improving Cervical Cancer Screening: HPV Self-Collection Tests
Endometrial Cancer Treatment Innovations